Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31404925.
- Also identified by DOI 10.7326/M19-1638.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The American Diabetes Association (ADA) annually updates its Standards of Medical Care in Diabetes to provide clinicians, patients, researchers, payers, and other interested parties with evidence-based recommendations for the diagnosis and management of patients with diabetes. The ADA Professional Practice Committee comprises physicians, adult and pediatric endocrinologists, diabetes educators, registered dietitians, epidemiologists, pharmacists, and public health experts. To develop the 2019 standards, the committee continuously searched MEDLINE through November 2018 to consider and review studies, particularly high-quality trials including persons with diabetes, for potential incorporation into recommendations. It also solicited feedback from the larger clinical community. This synopsis focuses on selected guidance relating to use of diabetes technology in adults with diabetes. Recommendations address self-monitoring of blood glucose, continuous glucose monitors, and automated insulin delivery systems.
Medical subject headings
- Blood Glucose
- Blood Glucose Self-Monitoring
- Diabetes Mellitus
- Hypoglycemic Agents
- Insulin
- Insulin Infusion Systems